Literature DB >> 13342511

Hypoglycaemic sulphonamides in treatment of diabetes.

G WALKER, W L LEESE, J D NABARRO.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/therapy; SULFONAMIDES/therapeutic use; UREA/derivatives

Mesh:

Substances:

Year:  1956        PMID: 13342511      PMCID: PMC2034813          DOI: 10.1136/bmj.2.4990.451

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  [THE HEMATOLOGICAL RISK IN TREATMENT WITH HYPOCLYCEMIC SULFONAMIDES].

Authors:  F J TRAISSAC; C BERAUD; J DANGOUMAU
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

2.  Experience with glipasol (R. P. 2259)-an antidiabetic sulfonamide drug.

Authors:  T W DAVIS; R B KERR; A BOGOCH
Journal:  Can Med Assoc J       Date:  1959-07-15       Impact factor: 8.262

3.  Clinical experience with tolbutamide.

Authors:  G WALKER; J D SLATER; E K WESTLAKE; J D NABARRO
Journal:  Br Med J       Date:  1957-08-10

4.  The estimation of BZ55 and sulphonamides in blood sugar filtrates.

Authors:  D G MOSS
Journal:  J Clin Pathol       Date:  1957-11       Impact factor: 3.411

5.  Carbutamide in juvenile diabetes.

Authors:  J M SMELLIE
Journal:  Br Med J       Date:  1958-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.